Skip to main content
. 2023 May 22;257:115491. doi: 10.1016/j.ejmech.2023.115491

Table 1.

SARS-CoV-2 Mpro inhibitors in clinical trials (www.clinicaltrials.gov).

Inhibitor Sponsor Phase Status Identifier
PF-07304814 Pfizer 1 Completed NCT04627532
PF-07304814 Pfizer 1 Completed NCT04535167
PF-07304814 Pfizer 1 Completed NCT05050682
Ebselen Sound Pharmaceuticals, Incorporated 2 Enrolling by invitation NCT04484025
Ebselen Sound Pharmaceuticals, Incorporated 2 Enrolling by invitation NCT04483973
Masitinib AB Science 2 Recruiting NCT04622865
Masitinib AB Science 2 Recruiting NCT05047783